This targeted formula also helps break down fiber and increases beneficial postbiotics and hormones, such as butyrate and GLP-1, which help maintain blood sugar levels
This dual-targeting approach enhances insulin sensitivity, promotes satiety, and has been shown to result in even more substantial weight loss than single-pathway medications
If you have taken Ozempic or a similar semaglutide and have been diagnosed with gallbladder disease, you may be eligible to file a semaglutide lawsuit against the products manufacturer
But Pfizer already has more than 20 anti-obesity trials planned for 2026, including 10 Phase 3 trials of PF'3944, one of which will measure the benefit of a weekly dosing
However, in specific contexts, GLP-1 has also been shown to exhibit cytotoxic effects
Mar 14 2025;23(1):211